AAAAAA
Results: 1-25/28
Authors:
Lawrie, LC
Curran, S
McLeod, HL
Fothergill, JE
Murray, GI
Citation: Lc. Lawrie et al., Application of laser capture microdissection and proteomics in colon cancer, J CL PATH-M, 54(4), 2001, pp. 253-258
Authors:
Pritchard, SC
Nicolson, MC
Lloret, C
McKay, JA
Ross, VG
Kerr, KM
Murray, GI
McLeod, HL
Citation: Sc. Pritchard et al., Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: Implications for MMP inhibition therapy, ONCOL REP, 8(2), 2001, pp. 421-424
Authors:
Dusseau, C
Murray, GI
Keenan, RA
O'Kelly, T
Krokan, HE
McLeod, HL
Citation: C. Dusseau et al., Analysis of uracil DNA glycosylase in human colorectal cancer, INT J ONCOL, 18(2), 2001, pp. 393-399
Authors:
Murray, GI
Melvin, WT
Greenlee, WF
Burke, MD
Citation: Gi. Murray et al., Regulation, function, and tissue-specific expression of cytochrome P450CYP1B1, ANN R PHARM, 41, 2001, pp. 297-316
Authors:
Rochat, B
Morsman, JM
Murray, GI
Figg, WD
Mcleod, HL
Citation: B. Rochat et al., Human CYP1B1 and anticancer agent metabolism: Mechanism for tumor-specificdrug inactivation?, J PHARM EXP, 296(2), 2001, pp. 537-541
Authors:
Murray, GI
Citation: Gi. Murray, Matrix metalloproteinases: a multifunctional group of molecules, J PATHOLOGY, 195(2), 2001, pp. 135-137
Authors:
Collie-Duguid, ESR
Johnston, SJ
Boyce, L
Smith, N
Cowieson, A
Cassidy, J
Murray, GI
McLeod, HL
Citation: Esr. Collie-duguid et al., Thymidine phosphorylase and dihydropyrimidine dehydrogenase protein expression in colorectal cancer, INT J CANC, 94(2), 2001, pp. 297-301
Authors:
Wright, MC
Issa, R
Smart, DE
Trim, N
Murray, GI
Primrose, JN
Arthur, MJP
Iredale, JP
Mann, DA
Citation: Mc. Wright et al., Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cellsand enhances the resolution of liver fibrosis in rats, GASTROENTY, 121(3), 2001, pp. 685-698
Authors:
McFadyen, MCE
Cruickshank, ME
Miller, ID
McLeod, HL
Melvin, WT
Haites, NE
Parkin, D
Murray, GI
Citation: Mce. Mcfadyen et al., Cytochrome P450CYP1B1 over-expression in primary and metastatic ovarian cancer, BR J CANC, 85(2), 2001, pp. 242-246
Authors:
McFadyen, MCE
McLeod, HL
Jackson, FC
Melvin, WT
Doehmer, J
Murray, GI
Citation: Mce. Mcfadyen et al., Cytochrome P450CYP1B1 protein expression: a novel mechanism of anticancer drug resistance, BIOCH PHARM, 62(2), 2001, pp. 207-212
Authors:
Curran, S
McKay, JA
McLeod, HL
Murray, GI
Citation: S. Curran et al., Laser capture microscopy, J CL PATH-M, 53(2), 2000, pp. 64-68
Authors:
McKay, JA
Douglas, JJ
Ross, VG
Curran, S
Ahmed, FY
Loane, JF
Murray, GI
McLeod, HL
Citation: Ja. Mckay et al., Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases, CLIN CANC R, 6(3), 2000, pp. 1113-1118
Authors:
McKay, JA
Lloret, C
Murray, GI
Johnston, PG
Bicknell, R
Ahmed, FY
Cassidy, J
McLeod, HL
Citation: Ja. Mckay et al., Application of the enrichment approach to identify putative markers of response to 5-fluorouracil therapy in advanced colorectal carcinomas, INT J ONCOL, 17(1), 2000, pp. 153-158
Authors:
Curran, S
Murray, GI
Citation: S. Curran et Gi. Murray, Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis, EUR J CANC, 36(13), 2000, pp. 1621-1630
Authors:
Murray, GI
Citation: Gi. Murray, The role of cytochrome P450 in tumour development and progression and its potential in therapy, J PATHOLOGY, 192(4), 2000, pp. 419-426
Authors:
Chambers, G
Lawrie, L
Cash, P
Murray, GI
Citation: G. Chambers et al., Proteomics: a new approach to the study of disease, J PATHOLOGY, 192(3), 2000, pp. 280-288
Authors:
McKay, JA
Douglas, JJ
Ross, VG
Curran, S
Murray, GI
Cassidy, J
McLeod, HL
Citation: Ja. Mckay et al., Cyclin D1 protein expression and gene polymorphism in colorectal cancer, INT J CANC, 88(1), 2000, pp. 77-81
Authors:
Jaffrey, RG
Pritchard, SC
Clark, C
Murray, GI
Cassidy, J
Kerr, KM
Nicolson, MC
McLeod, HL
Citation: Rg. Jaffrey et al., Genomic instability at the BUB1 locus in colorectal cancer, but not in non-small cell lung cancer, CANCER RES, 60(16), 2000, pp. 4349-4352
Authors:
McFadyen, MCE
Murray, GI
Melvin, WT
Citation: Mce. Mcfadyen et al., Cytochrome P450CYP1B1 mRNA in normal human brain, J CL PATH-M, 52(3), 1999, pp. 164-164
Authors:
King, G
Chambers, G
Murray, GI
Citation: G. King et al., Detection of immunoglobulin light chain mRNA by in situ hybridisation using biotinylated tyramine signal amplification, J CL PATH-M, 52(1), 1999, pp. 47-50
Authors:
McLeod, HL
Murray, GI
Mollison, J
McKay, J
Cassidy, J
Citation: Hl. Mcleod et al., Selection of markers to predict tumour response or survival: Description of a novel approach, EUR J CANC, 35(12), 1999, pp. 1650-1652
Authors:
Ahmed, FY
Johnston, SJ
Cassidy, J
O'Kelly, T
Binnie, N
Murray, GI
van Gennip, AH
Abeling, NGGM
Knight, S
McLeod, HL
Citation: Fy. Ahmed et al., Eniluracil treatment completely inactivates dihydropyrimidine dehydrogenase in colorectal tumors, J CL ONCOL, 17(8), 1999, pp. 2439-2445
Authors:
Cheung, YL
Kerr, AC
McFadyen, MCE
Melvin, WT
Murray, GI
Citation: Yl. Cheung et al., Differential expression of CYP1A1, CYP1A2, CYP1B1 in human kidney tumours, CANCER LETT, 139(2), 1999, pp. 199-205
Authors:
Curran, S
Murray, GI
Citation: S. Curran et Gi. Murray, Matrix metalloproteinases in tumour invasion and metastasis, J PATHOLOGY, 189(3), 1999, pp. 300-308
Authors:
McFadyen, MCE
Breeman, S
Payne, S
Stirk, C
Miller, ID
Melvin, WT
Murray, GI
Citation: Mce. Mcfadyen et al., Immunohistochemical localization of cytochrome P450CYP1B1 in breast cancerwith monoclonal antibodies specific for CYP1B1, J HIST CYTO, 47(11), 1999, pp. 1457-1464